The use of CCBs declined after November 2016, although this difference did not reach statistical significance (41% before vs. 25% after, p = 0.13).
← all excerpts
Rheumatologists' Adherence to EULAR Recommendations for Systemic Sclerosis Treatment: Experience of a Single Center in Serbia.
1
0.1300
0.1300